Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2013-05-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1302792110PMID 23671107PMCID PMC3670309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The ubiquitin system, an immense realm.

  2012cited by this paper
• HECT and RING finger families of E3 ubiquitin ligases at a glance

  2012cited by this paper
• Balancing Arc Synthesis, mRNA Decay, and Proteasomal Degradation

  2012cited by this paper
• Rapid Estrogen Signaling in the Brain: Implications for the Fine-Tuning of Neuronal Circuitry

  2011cited by this paper
• Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases

  2011cited by this paper
• E6-AP facilitates efficient transcription at estrogen responsive promoters through recruitment of chromatin modifiers.

  2011cited by this paper
• Increased Gene Dosage of Ube3a Results in Autism Traits and Decreased Glutamate Synaptic Transmission in Mice

  2011influential reference
• Physical and Functional Interaction of the HECT Ubiquitin-protein Ligases E6AP and HERC2*

  2011cited by this paper
• Molecular and Clinical Aspects of Angelman Syndrome

  2011cited by this paper
• Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of Angelman syndrome

  2010cited by this paper
• Special issue on estrogen actions in the brain.

  2010cited by this paper
• The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13.

  2010cited by this paper
• Estrogen-mediated effects on cognition and synaptic plasticity: what do estrogen receptor knockout models tell us?

  2010cited by this paper
• Isoform-specific degradation of PR-B by E6-AP is critical for normal mammary gland development.

  2010cited by this paper
• The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.

  2010cited by this paper
• Ubiquitin-fusion protein system: a powerful tool for ectopic protein expression in mammalian cells.

  2009cited by this paper
• Autism genome-wide copy number variation reveals ubiquitin and neuronal genes

  2009cited by this paper
• Ube3a is required for experience-dependent maturation of the neocortex

  2009cited by this paper
• Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.

  2009cited by this paper
• Ubiquitin-binding domains — from structures to functions

  2009cited by this paper
• E6AP promotes the degradation of the PML tumor suppressor

  2009cited by this paper
• The ubiquitin receptor Rad23: at the crossroads of nucleotide excision repair and proteasomal degradation.

  2009cited by this paper
• Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology.

  2009cited by this paper
• The ubiquitin ligase E6‐AP promotes degradation of α‐synuclein

  2009cited by this paper
• Estrogen stimulates activity-regulated cytoskeleton associated protein (Arc) expression via the MAPK- and PI-3K-dependent pathways in SH-SY5Y cells.

  2009influential reference
• The Immediate Early Gene Arc/Arg3.1: Regulation, Mechanisms, and Function

  2008cited by this paper
• HPV E6, E6AP and cervical cancer

  2007cited by this paper
• The Role of the Ubiquitin Ligase E6-AP in Human Papillomavirus E6-mediated Degradation of PDZ Domain-containing Proteins*

  2007influential reference
• Modification of proteins by ubiquitin and ubiquitin-like proteins.

  2006cited by this paper
• Genome-wide analysis of estrogen receptor binding sites

  2006cited by this paper
• E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells.

  2006cited by this paper
• E6AP and Calmodulin Reciprocally Regulate Estrogen Receptor Stability*

  2006cited by this paper
• Ubiquitin fusion technique and related methods.

  2005cited by this paper
• Growth Suppression Induced by Downregulation of E6-AP Expression in Human Papillomavirus-Positive Cancer Cell Lines Depends on p53

  2005cited by this paper
• The -4 Phenylalanine Is Required for Substrate Ubiquitination Catalyzed by HECT Ubiquitin Ligases*

  2004cited by this paper
• Structure of the XPC binding domain of hHR23A reveals hydrophobic patches for protein interaction

  2004influential reference
• Muscarinic acetylcholine receptor stimulation induces expression of the activity-regulated cytoskeleton-associated gene (ARC).

  2004cited by this paper
• Biochemical Analysis of Angelman Syndrome-associated Mutations in the E3 Ubiquitin Ligase E6-associated Protein*

  2004cited by this paper
• Angelman syndrome: a review of the clinical and genetic aspects

  2003cited by this paper
• E6AP gene suppression and characterization with in vitro selected hammerhead ribozymes

  2003cited by this paper
• Involvement of the DNA Repair Protein hHR23 inp53Degradation

  2003cited by this paper
• Disruption of estrogen receptor beta gene impairs spatial learning in female mice.

  2002cited by this paper
• Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice.

  2002cited by this paper
• Disruption of estrogen receptor β gene impairs spatial learning in female mice

  2002cited by this paper
• Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes.

  2001cited by this paper
• Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods.

  2000cited by this paper
• Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro.

  1999cited by this paper
• Identification of HHR23A as a Substrate for E6-associated Protein-mediated Ubiquitination*

  1999cited by this paper
• The Angelman Syndrome-Associated Protein, E6-AP, Is a Coactivator for the Nuclear Hormone Receptor Superfamily

  1999cited by this paper
• The spectrum of mutations in UBE3A causing Angelman syndrome.

  1999cited by this paper
• Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation.

  1998cited by this paper
• Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation

  1998cited by this paper
• The Role of E6AP in the Regulation of p53 Protein Levels in Human Papillomavirus (HPV)-positive and HPV-negative Cells*

  1998cited by this paper
• De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome

  1997cited by this paper
• Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells

  1997cited by this paper
• Estrogen facilitates induction of long term potentiation in the hippocampus of awake rats.

  1997cited by this paper
• The human E6-AP gene (UBE3A) encodes three potential protein isoforms generated by differential splicing.

  1997cited by this paper
• UBE3A/E6-AP mutations cause Angelman syndrome

  1996cited by this paper
• The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53.

  1993cited by this paper
• Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53

  1993cited by this paper
• A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.

  1991cited by this paper
• In vivo half-life of a protein is a function of its amino-terminal residue.

  1986cited by this paper

• Dysregulation of neuronal activity-dependent immediate early genes in a mouse model of Angelman syndrome

  2025cites this paper
• Angelman Syndrome: An Updated Review of Pathophysiology, Diagnosis and Management

  2025cites this paper
• Role of androgen receptors in sexually dimorphic phenotypes in UBE3A-dependent autism spectrum disorder

  2025cites this paper
• Dysfunction of the Autophagy System and MDM2–p53 Axis Leads to the Accumulation of Amyloidogenic Proteins in Angelman Syndrome Models

  2025cites this paper
• Disease-associated polyalanine expansion mutations impair UBA6-dependent ubiquitination

  2024cites this paper
• The role of glia in the dysregulation of neuronal spinogenesis in Ube3a-dependent ASD.

  2024cites this paper
• Multiscale spatio-temporal dynamics of UBE3A gene in brain physiology and neurodevelopmental disorders.

  2024cites this paper
• Prenatal Exposure to Azadiradione Leads to Developmental Disabilities

  2024cites this paper
• Pin1 promotes human CaV2.1 channel polyubiquitination by RNF138: pathophysiological implication for episodic ataxia type 2

  2024cites this paper
• A Survey on the Expression of the Ubiquitin Proteasome System Components HECT- and RBR-E3 Ubiquitin Ligases and E2 Ubiquitin-Conjugating and E1 Ubiquitin-Activating Enzymes during Human Brain Development

  2024cites this paper
• UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes

  2024cites this paper
• Azadiradione up-regulates the expression of parvalbumin and BDNF via Ube3a.

  2023cites this paper
• UBE3A: The Role in Autism Spectrum Disorders (ASDs) and a Potential Candidate for Biomarker Studies and Designing Therapeutic Strategies

  2023cites this paper
• An Association Study of DNA Methylation and Gene Expression in Angelman Syndrome: A Bioinformatics Approach

  2022cites this paper
• 'Arc'-hitecture of normal cognitive aging.

  2022cites this paper
• Polyalanine disease mutations impair UBA6-dependent ubiquitination

  2022cites this paper
• E3 ligases: a potential multi-drug target for different types of cancers and neurological disorders.

  2022cites this paper
• Excessive Protein Accumulation and Impaired Autophagy in the Hippocampus of Angelman Syndrome Modeled in Mice.

  2022cites this paper
• Digital The autism-linked UBE3A T485A mutant E3 ubiquitin ligase The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/ β -catenin pathway by inhibiting the proteasome activates the Wnt/ -catenin pathway by inhibiting the proteasome

  2022cites this paper
• Sex-biasing influence of autism-associated Ube3a gene overdosage at connectomic, behavioral, and transcriptomic levels

  2022cites this paper
• Molecular and behavioral consequences of Ube3a gene overdosage in mice

  2022cites this paper
• Exploring the "other" subfamily of HECT E3-ligases for therapeutic intervention.

  2021cites this paper
• The role of E3 ubiquitin ligases in synapse function in the healthy and diseased brain.

  2021cites this paper
• UBE3A reinstatement as a disease‐modifying therapy for Angelman syndrome

  2021influential citation
• Identification of UBE3A Protein in CSF and Extracellular Space of the Hippocampus Suggest a Potential Novel Function in Synaptic Plasticity

  2021cites this paper
• CHIP promotes Wnt signaling and regulates Arc stability by recruiting and polyubiquitinating LEF1 or Arc

  2021cites this paper
• Secreted retrovirus-like GAG-domain-containing protein PEG10 is regulated by UBE3A and is involved in Angelman syndrome pathophysiology

  2021cites this paper
• Identification of disease-linked hyperactivating mutations in UBE3A through large-scale functional variant analysis

  2021cites this paper
• Induced pluripotent stem cells for modeling Angelman syndrome

  2021cites this paper
• Hyperexcitable Phenotypes in Induced Pluripotent Stem Cell-Derived Neurons From Patients With 15q11-q13 Duplication Syndrome, a Genetic Form of Autism.

  2021cites this paper
• Ubiquitin and Ubiquitin-Like Proteins in the Critical Equilibrium between Synapse Physiology and Intellectual Disability

  2020cites this paper
• New genes involved in Angelman syndrome-like: Expanding the genetic spectrum

  2020cites this paper
• Angelman syndrome: a journey through the brain

  2020cites this paper
• Angelman syndrome: from mouse models to therapy.

  2020cites this paper
• Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function

  2020cites this paper
• Study of adhesion and migration dynamics in ubiquitin E3A ligase (UBE3A)-silenced SYSH5Y neuroblastoma cells by micro-structured surfaces

  2020cites this paper
• A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome

  2020cites this paper
• A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6

  2020cites this paper
• The HECT E3 Ligase E6AP/UBE3A as a Therapeutic Target in Cancer and Neurological Disorders

  2020cites this paper
• Cortical network dynamics are coupled with cognitive aging in rats

  2019cites this paper
• Intellectual disability and autism spectrum disorders ‘on the fly’: insights from Drosophila

  2019cites this paper
• Towards an understanding of Angelman syndrome in mice studies

  2019cites this paper
• The Autism and Angelman Syndrome Protein Ube3A/E6AP: The Gene, E3 Ligase Ubiquitination Targets and Neurobiological Functions

  2019influential citation
• UBE3A regulates the transcription of IRF, an antiviral immunity.

  2019cites this paper
• Sex-Dependent Sensory Phenotypes and Related Transcriptomic Expression Profiles Are Differentially Affected by Angelman Syndrome

  2019cites this paper
• Dysfunction of the ubiquitin ligase E3A Ube3A/E6-AP contributes to synaptic pathology in Alzheimer’s disease

  2019cites this paper
• HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.

  2019cites this paper
• Characterization of the role of E6-AP in Angelman Syndrome and Similar Neurodevelopmental Disorders

  2019cites this paper
• Loss of nuclear UBE3A causes electrophysiological and behavioral deficits in mice and is associated with Angelman syndrome

  2019cites this paper
• Insights into the ubiquitin-proteasome system of human embryonic stem cells

  2018cites this paper
• Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model.

  2018cites this paper
• Network Analysis of UBE3A/E6AP-Associated Proteins Provides Connections to Several Distinct Cellular Processes.

  2018cites this paper
• Adult Ube3a Gene Reinstatement Restores the Electrophysiological Deficits of Prefrontal Cortex Layer 5 Neurons in a Mouse Model of Angelman Syndrome

  2018cites this paper
• Angelman syndrome–associated point mutations in the Zn2+-binding N-terminal (AZUL) domain of UBE3A ubiquitin ligase inhibit binding to the proteasome

  2018cites this paper
• Subcellular organization of UBE3A in human cerebral cortex

  2018cites this paper
• Structural dynamics of the E6AP/UBE3A-E6-p53 enzyme-substrate complex

  2018cites this paper
• Generation of Isogenic Human Pluripotent Stem Cell-Derived Neurons to Establish a Molecular Angelman Syndrome Phenotype and to Study the UBE3A Protein Isoforms

  2018cites this paper
• Hyperexcitable phenotypes in iPSC-derived neurons from patients with 15q11-q13 duplication syndrome, a genetic form of autism

  2018cites this paper
• Synaptopathology Involved in Autism Spectrum Disorder

  2018cites this paper
• UBE3A and Its Link With Autism

  2018cites this paper
• OTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion Syndrome

  2018cites this paper
• Roles for Arc in metabotropic glutamate receptor-dependent LTD and synapse elimination: Implications in health and disease.

  2017cites this paper
• LDAP: a web server for lncRNA-disease association prediction

  2017cites this paper
• Arc protein: a flexible hub for synaptic plasticity and cognition.

  2017cites this paper
• Arc ubiquitination in synaptic plasticity.

  2017cites this paper
• Transcriptional and post-translational regulation of Arc in synaptic plasticity.

  2017cites this paper
• Autism gene Ube3a and seizures impair sociability by repressing VTA Cbln1

  2017cites this paper
• NPAS 1 and NPAS 3 are master regulators of neuropsychiatric risk genes

  2017cites this paper
• Neuronal overexpression of Ube3a isoform 2 causes behavioral impairments and neuroanatomical pathology relevant to 15q11.2‐q13.3 duplication syndrome

  2017cites this paper
• The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasome

  2017cites this paper
• Dynamic Arc SUMOylation and Selective Interaction with F-Actin-Binding Protein Drebrin A in LTP Consolidation In Vivo

  2017cites this paper
• Pharmacological therapies for Angelman syndrome

  2017cites this paper
• Ubiquitination and the Regulation of Membrane Proteins.

  2017cites this paper
• E3 Ubiquitin Ligases Neurobiological Mechanisms: Development to Degeneration

  2017cites this paper
• Activity-Dependent Arc Expression and Homeostatic Synaptic Plasticity Are Altered in Neurons from a Mouse Model of Angelman Syndrome

  2017influential citation
• Ubiquitin Ligase RNF138 Promotes Episodic Ataxia Type 2-Associated Aberrant Degradation of Human Cav2.1 (P/Q-Type) Calcium Channels

  2017cites this paper
• mRNA Trafficking to Synapses and Memory Formation

  2017cites this paper
• Molecular Players in Preserving Excitatory-Inhibitory Balance in the Brain

  2017cites this paper
• The E3 ubiquitin ligase HACE1 : characterization of its regulation by phosphorylation and demonstration of its role in cellular cohesion

  2017cites this paper
• Perturbed proteostasis in autism spectrum disorders

  2016cites this paper
• Comprehensive Study of the Stability of Genomic Imprinting during Mouse iPSC Reprogramming

  2016cites this paper
• Angelman syndrome — insights into a rare neurogenetic disorder

  2016cites this paper
• Co-Translational Folding: A Novel Modulator of Local Protein Expression in Mammalian Neurons?

  2016cites this paper
• Potential therapeutic approaches for Angelman syndrome

  2016cites this paper
• Running title: Perturbed proteostasis in autism

  2016cites this paper
• A Behavioral and Molecular Approach for Understanding Angelman Syndrome

  2016cites this paper
• mTORC1–S6K1 inhibition or mTORC2 activation improves hippocampal synaptic plasticity and learning in Angelman syndrome mice

  2016cites this paper
• In vivo strategies for the study of ubiquitination and ubiquitin-related diseases: application to Angelman syndrome

  2016cites this paper
• Monogenic mouse models of autism spectrum disorders: Common mechanisms and missing links.

  2016cites this paper
• Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila

  2016cites this paper
• Angelman syndrome: Current and emerging therapies in 2016

  2016cites this paper
• Modeling Neurodevelopmental Disorders Involving Genomic Imprinting at Human Chromosome 15q11-q13 Using iPSC and CRISPR/Cas9 Technology

  2016cites this paper
• GABAergic Neuron-Specific Loss of Ube3a Causes Angelman Syndrome-Like EEG Abnormalities and Enhances Seizure Susceptibility.

  2016cites this paper
• Perturbed proteostasis in autism spectrum disorders

  2016cites this paper
• LDAP: a web server for lncRNA‐disease association prediction

  2016cites this paper
• Bimolecular Fluorescence Complementation to Assay the Interactions of Ubiquitylation Enzymes in Living Yeast Cells.

  2016cites this paper
• Overexpression of dominant-negative Ire1 enzyme in H1299-shE6AP cells increases heat shock element-dependent transcription

  2015cites this paper
• Seizure-like activity in a juvenile Angelman syndrome mouse model is attenuated by reducing Arc expression

  2015cites this paper
• A novel form of synaptic plasticity in field CA3 of hippocampus requires GPER1 activation and BDNF release

  2015cites this paper
• From UBE3A to Angelman syndrome: a substrate perspective

  2015cites this paper